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Abstract 
Background and objectives: Initiation of epidural anesthesia with long-lasting local anesthetics 
consumes a signiﬁ cant amount of time, which could be problematic in busy obstetric anesthesia 
suites. We have hypothesized that a combination of articaine and ropivacaine provides faster 
onset and even an early recovery of sensory-motor block characteristics. 
Methods: Sixty term parturients scheduled to have elective cesarean section were randomly 
allocated into three groups to receive either 20 mL 2% articaine (Group A), 10 mL 2% articaine 
+ 10 mL 0.75% ropivacaine (Group AR) or 20 mL 0.75% ropivacaine (Group R) via lumbar epidural 
catheter. The onset time of sensory block to T10, T6 and maximum sensory block level, time to 
two segments regression from maximum sensory block level, onset time and duration of motor 
block were all recorded. Intraoperative and postoperative additional analgesic requirements 
were also recorded. 
Results: Demographic data were similar. The onset times of sensorial block to T10 and T6 were 
signiﬁ cantly shorter in Groups A and AR in comparison with Group R (p < 0.05). The onset times of 
motor block were similar in all groups, but a more intense motor block was observed in Group R 
(p < 0.05). Two segments regression time and motor block durations were signiﬁ cantly shorter in 
Groups A and AR in comparison with Group R (p < 0.05). Intraoperative supplementary analgesic 
requirements were higher in Group A than in the other two groups (p < 0.05). 
Conclusion: A combination of 2% articaine and 0.75% ropivacaine for epidural anesthesia in a 
cesarean section should be preferred over epidural 0.75% ropivacaine alone. 
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
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Introduction
Epidural anesthesia allows the adjustment of intraoperative 
sensory block level with a catheter and offers postoperative 
analgesia 1,2. However, the time needed for the provision of 
adequate sensory block in epidural anesthesia constitutes a 
problem for busy obstetric anesthesia operation theatres 1-3. 
This is especially important when long-lasting local anesthet-
ics are used for epidural anesthesia.
None of the local anesthetics in current practice carry 
properties such as fast onset of action, long sensory block 
duration and short motor block duration to enable early mo-
bilization after epidural anesthesia. In order to avail these 
properties, adjuvants have been used with local anesthetics 4-9 
or local anesthetics with different properties have been com-
bined 10. Ropivacaine, due to its weaker motor block effect, 
has become popular for obstetric anesthesia and analgesia in 
the last two decades. However, ropivacaine provides a similar 
speed of sensory block onset as bupivacaine but does not pro-
vide faster onset for epidural anesthesia 11-13. An amide group 
local anesthetic, articaine, has a fast onset and offset time 
due to its high lipid solubility 14,15. Articaine has a short sensory 
and motor block onset of action and low toxicity proﬁ le; its 
use had been described for epidural anesthesia 15-18. The use 
of combinations of different local anesthetics for epidural 
anesthesia in cesarean surgeries has been studied in the lit-
erature 9,10, however we did not come across any study that 
combines articaine and ropivacaine for epidural anesthesia.
We have hypothesized that a combination of articaine 
and ropivacaine for epidural anesthesia of cesarean sec-
tions could provide faster onset and yet longer postopera-
tive analgesia with minimal motor blockade. The primary 
outcome was sensory block onset time. Thus, we compared 
the sensory and motor block characteristics of epidural an-
esthesia with the use of ropivacaine and articaine, in equal 
amounts, separately and combined for patients selected for 
cesarean section.
Methods
Prior to the study, the chromatograms of 0.75% ropivacaine 
and 2% articaine were analyzed both separately and in a 
solution of both mixed in equal volumes by using a Gas 
Chromatography/Mass Spectrometry device (GC/MS; Agilent 
6890 GS System 5973 MDS, Germany) 19 (Figure 1). The pH 
of the local anesthetics alone and mixed solutions were 
determined. 
After obtaining hospital ethics board approval and written 
informed consents from patients, 60 pregnant women over 
the age of 18 from the ASA I-II risk group who were scheduled 
for elective cesarean surgery were included in the study. 
Exclusion criteria included: history of preeclampsia, psychi-
atric disorders and allergies to amid type local anesthetics, 
as well as pregnancy terms other than 36-40 weeks, multi-
ple pregnancies, and other contra-indications for epidural 
anesthesia. All patients in the study were introduced to the 
Patient Controlled Analgesia (PCA) device and informed on 
how to use it. 
Patients were randomly distributed by a computer into 
three groups consisting of 20 patients each. The following 
procedures were planned for each group:
Group A: 20 mL 2% articaine + 1 mL fentanyl (50 μg) 
Group AR: 10 mL 0.75% ropivacaine + 10 mL 2%  articaine 
+ 1 mL fentanyl (50 μg)
Group R: 20 mL 0.75% ropivacaine + 1 mL fentanyl 
(50 μg)  
Anesthetic Procedures
Premedication was not administered to any patient. They 
were admitted to the operation theatre after gaining vas-
cular access and being administered 10 mL.kg-1 0.9% NaCl 
intravenous (iv) infusion in 15 minutes. Following this, the same 
ﬂ uid was used as maintenance infusion at 5 mL.kg-1.hr-1. Each 
patient on the operating table was monitored by non-invasive 
methods, and the following parameters were recorded as a 
baseline value for hemodynamic measurements: mean arte-
rial blood pressure (MBP), heart rate (HR), and peripheral O2 
saturation (SpO2) (Odam Physiogards SM 785, France). Epidural 
catheter was inserted at the better interspace of L2-3 or L3-4 
when in a sitting position; then, the patients laid down on 
the operation table. The operation table was rotated 15° 
to the left and all patients were given 3 L.min-1 O2 by nasal 
catheter. A nurse anesthetist prepared the local anesthetic 
solution (Ultracain, Sanoﬁ  Aventis, Turkey; Naropin, Astra-
Zeneca, Turkey) according to randomization. All patients 
received a 3 mL test dose of the prepared local anesthetic 
initially, then 50 μg fentanyl and 17 mL of the same local 
anesthetic solution epidurally. The patients, as well as the an-
esthesiologist administering the drug and evaluating the block 
characteristics were unaware of the group allocations. 
When sensory block did not reach T6 20 minutes after the 
injection of local anesthetic, 2 mL medication used in the 
study group was administered every 3 minutes, until block 
level reached T6. The operation was initiated when sensory 
block reached the T6 dermatome. In cases of insufﬁ cient 
analgesia - despite sensory block having reached the T6 der-
matome - the plan was for the patient to be evaluated by 
using the Visual Analog Scale (VAS; 0: no pain, 10: worst pain 
imaginable), and any VAS ≥ 3 patient would be administered 
iv fentanyl (50 μg). If not sufﬁ cient, they received a bolus 
dose of iv ketamine (10 mg). There was a plan for general 
anesthesia in case the pain could not be controlled by ad-
ditional iv analgesic. 
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Figure 1  Cranial Spread of Sensory Block Levels within the 
Groups (Median).
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Cases where MBP decreased by 20% as compared to 
baseline values were treated with rapid ﬂ uid replacement 
and 5 mg of ephedrine in bolus doses. When HR decreased 
below 50 beats.min-1, administration of 0.5 mg iv atropine 
was planned. In cases of nausea, 10 mg iv metoclopramide 
was planned. We took note of all drug applications and 
doses. 
Block evaluations
We identiﬁ ed the dermatomal spread of sensory block in 
the cranial direction with a 25-Gauge needle “pin prick” 
test on the bilateral midclavicular line. We identiﬁ ed SpO2 
with hemodynamic parameters every 2.5 minutes during the 
ﬁ rst 20 minutes after local anesthetic injection and every 
5 minutes thereafter until the end of surgery; in the post-
operative stage, every 30 minutes until minute 180. Motor 
block levels were recorded by using Modiﬁ ed Bromage Scale 
(MBS) (0= No block, 1= Difﬁ culty lifting leg, 2= Difﬁ culty with 
ﬂ exion at knee joint, 3= Difﬁ culty with ﬂ exion at ankle) every 
2.5 minutes for the ﬁ rst 17.5 minutes after epidural local 
anesthetic injection and every 30 minutes until minute 180 
in the postoperative stage. 
We took note of the following: times needed for sensory 
block to reach T10, T6 and maximum levels, for regression 
from maximum sensory block by two dermatomes, and for 
sensory block to regress to the T10 dermatome. Motor block 
onset time was deﬁ ned and noted as the time between 
epidural injection to MBS 1, and total motor block duration 
was deﬁ ned and noted as the time between motor block 
onset to MBS 0.
During the operation, the upper level of sensory block 
was assessed with the pinprick test during skin incision, the 
head of the baby being born, exposition of the uterus, clo-
sure of the peritoneum and skin suturing, and level of pain 
was assessed with VAS. Minutes 1 and 5 Apgar scores of the 
newborns were recorded.
After the operation, patients and surgeons evaluated the 
efﬁ ciency of epidural anesthesia as poor, moderate, good, 
or very good.
Postoperative follow-up
When the sensory block has regressed two dermatomes from 
its maximum level, 3 mg morphine in saline was administered 
through the epidural catheter.  Additionally, all patients 
were given a Patient Controlled Analgesia Device (Abbott, 
Pain Management Provider, USA) and a standard analgesia 
protocol (2 mg.mL-1 ropivacaine and 2 μg.mL-1 fentanyl; 
6 mL bolus, 15 min lock-out time) for rescue analgesia. If 
additional analgesia was needed despite the PCA device we 
administered 20 mg tenoxicam (Tilcotil®, Roche, Sweden) 
every 12 hours.
We recorded the time of the ﬁ rst mobilization and pas-
sage of bowel gas in the postoperative stage. The data of 
PCA device and the need for additional analgesia were also 
noted in the protocol. 
Side effects
We also noted possible side effects (nausea, vomiting, shiver-
ing) in the parturients during the perioperative stage.
Sample size calculation
We put forth the hypothesis that a combination of artic-
aine and ropivacaine would produce a faster sensory block 
onset time for epidural anesthesia of cesarean sections in 
comparison with ropivacaine alone. The primary endpoint 
was the onset time of sensory block to T10. Sample size 
estimation was based on the similar study performed by 
Arslan et al. 20. 
In order to detect a 25% change in the onset time of sen-
sory block (8.7 ± 2.05 minutes in the previous study), with α 
error of 0.05 and a power of 90%, we calculated that sample 
size should be at least 19 patients per group. Twenty patients 
were enrolled in the groups. The sample size estimation was 
performed using Power Calculator 21. 
Statistical analysis
Statistical analysis was performed by using the Statistical 
Package for the Social Sciences (SPSS) version 16.0 for 
Windows (SPSS Inc., Chicago, IL, USA). Descriptive statistics 
included median and interquartile range (IQR) (%25-%75) for 
the numerical data, numbers and percentages for categorical 
data. Kolmogorov-Smirnov test was used to examine compat-
ibility between measured variables and normal distribution. 
Mann-Whitney U test was used to compare the averages of 
data with continuous measures such as: age, height, weight, 
gestational age, time needed for sensory block to reach T6, 
T10, motor block duration and ﬁ rst ephedrine time values. The 
Wilcoxon Signed Ranks Test was used to compare intragroup 
repeated measures, and the χ2 test was used to compare data 
that denotes frequency, such as gender and ASA risk category. 
A p value < 0.05 (after Bonferroni correction, p < 0.0166) was 
considered of statistical signiﬁ cance. 
Results
The chromatograms revealed that 2% articaine and 0.75% 
ropivacaine did not react with each other and the amounts 
of each drug in the mixture did not change. The pH of 2% 
articaine was 4.16, that of 0.75% ropivacaine was 5.06, and 
that of the solution made by mixing equal volumes of artic-
aine and ropivacaine was 4.39. 
There was no signiﬁ cant difference between the demo-
graphic data, pregnancy terms and surgical durations of the 
groups (p > 0.0166) (Table 1).
Block characteristics
While the time needed for sensory block to reach T10 and T6 
dermatomes and the maximum level were similar in Groups A 
and AR, these durations were shorter than Group R (p < 0.05). 
Maximum block levels were similar across groups; however, 
the time needed for regressing from the maximum block 
by two dermatomes and the time needed for sensory block 
to regress to T10 in Group AR were longer than Group A and 
shorter than Group R (p < 0.05) (Table 2). 
The levels of sensory block in the cranial direction were 
higher in Groups A and AR than Group R at minutes 5, 7.5, 
10, 12.5 and 15 (p < 0.05) (Figure 1).
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Intraoperative sensory block levels in Group A were 
lower than Group R during the birth of the baby’s head, 
exposition of the uterus and closure of the peritoneum, and 
lower than Groups AR and R during skin suturing (p < 0.05) 
(Figure 1).
Motor block onset was similar between the groups. Total 
motor block durations were shorter in Group A as compared 
to Groups AR and R, and in Group AR as compared to Group R 
(p < 0.05). Longer lasting and more dense motor block, accord-
ing to MBS, was observed in Group R (p < 0.05) (Table 2).
Total intraoperative fentanyl and ketamine usage were 
higher in Group A in comparison with Groups AR and R 
(p < 0.05). There was no statistical signiﬁ cance between 
Groups AR and R in terms of total fentanyl and ketamine 
need. (Table 3). None of the patients required a shift to 
general anesthesia for inadequate sensory block. 
Mean total local anesthetic volumes used in order to 
obtain adequate sensory block level to start surgery was 
22.6 ± 1.8 mL in Group A, 21.7 ± 1.2 mL in Group AR, and 
22.3 ± 1.8 mL in Group R (p > 0.05).
Hemodynamic data
A comparison of hemodynamics showed that the MBP in 
groups were as follow: MBP in Groups A and AR was lower 
than Group R at minute 5, and, in Group A, it was higher than 
Group R at minute 15 (p > 0.05). In the postoperative stage, 
MBPs remained higher in Group A than in Groups AR and R 
(p < 0.05). Comparisons within groups showed that all meas-
urements in Group A at minutes 5, 7.5, 10 and 12.5, Group 
AR at minutes 5, 7.5, 10, 12.5, 15 and 25, and Group R at 
minute 7.5 through the end of the operation were statistically 
lower than the control value (p < 0.05). While a signiﬁ cant 
difference was not detected among the groups with respect 
to HR, the HR value within Group R remained higher than 
control values from minute 17.5 onwards (p < 0.05). In our 
study, bradycardia was observed in three patients (15%) in 
both articaine and ropivacaine groups and in four patients 
(20%) in the combined articaine and ropivacaine group. 
It was treated by administering 0.5 mg atropine iv bolus. 
First intraoperative ephedrine administration times were 
compared between groups and Group A was found to have 
earlier administration times than Group R (p < 0.05), while 
Table 2  Time Needed for Sensory Block (SB) to Reach T10, T6 and Motor Block (MB) Durations (Mean ± SD).
Group A
(n = 20)
Group AR
(n = 20)
Group R
(n = 20)
Time for SB to reach T10 (min) 3.2 
(2.5-4) †
3.7 
(3-4.4) ‡
5 
(5-7.1)
Time for SB to reach T6 (min) 7.5 
(7.5-10) †
10 
(7.5-12.5) ‡
15.5 
(12.5-20)
Time for SB to reach its maximum (min) 12.5 
(10-12.5) †
15 
(12.5-15) ‡
20 
(20-28.7)
Maximum SB level T5 T5 T4
Time for SB to regress to T6  (min) 144 
(119-189)* †
225 
(203-240) ‡
281 
(252-318)
Two dermatome regression time, SB (min) 89 
(78-99)* †
125 
(120-150) ‡
156 
(130-184)
MB onset time (min) 12.5 
(7.5-15)
12.5 
(10-14.4)
12.5 
(12.5-15.0)
Total MB duration (min) 72.5
(55-87.5)* †
101.25 
(90-135.6) ‡
192.5 
(162.5-245.0)
*: p < 0.0166, between group A and  group AR, Mann-Whitney U test;
†: p < 0.0166, between group A and group R, Mann-Whitney U test;
‡: p < 0.016, betwen group R and  group AR, Mann-Whitney U test.
Table 1  Demographic Data, and Surgical Durations According to the Groups (Median, IQR).
Group A (n = 20) Group AR (n = 20) Group R (n = 20)
Age (year) 34 (26.2-34.7) 29 (26.2-33.0) 29 (26.5-34.0)
Height (cm) 162 (158.5-164.7) 160 (157.5-164.0) 161 (159.0-165.0)
Weight (kg)
Gestational age (week)
Surgical duration (min)
76 (69.2-83.5)
38 (38-38)
33 (30.0-39.7)
72 (65.5-79.7)
38 (38-38)
30 (28.0-37.0)
74 (69.5-78.7)
39 (38-39)
31 (30.0-34.0)
IQR: interquartile range.
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Groups AR and R were similar (Table 3). When total ephedrine 
amounts were compared, the total amount in Group A was 
higher than in Group R (p < 0.05) (Table 3).
Minutes 1 and 5 Apgar scores of newborns were similar 
in all groups. None of the patients and surgeons reported 
poor satisfaction in the postoperative assessment, however 
Group A had a signiﬁ cantly lower satisfaction scores compared 
to Groups AR and R (p < 0.05).
Postoperative analgesia and recovery
The number of times patients pressing the button of the PCA 
device for their analgesic needs and the number of times the 
device administered medication to meet these needs were 
statistically higher in Group A than in Group R (p < 0.05) 
(Table 4). The time of ﬁ rst mobilization was shorter in Groups 
A and AR than in Group R (p < 0.05). The time of ﬁ rst gas 
passage was earlier in Group A than in Groups AR and R, and 
in Group AR than in Group R (p < 0.05) (Table 4).
Side effects
The groups were not different in terms of side effect data 
observed (p > 0.05).
Discussion
The results of our study have demonstrated that admin-
istering epidural anesthesia with a combination of 0.75% 
ropivacaine and 2% articaine shortens onset of anesthesia 
in comparison with using 0.75% ropivacaine alone and pro-
vides longer anesthesia duration than 2% articaine. Motor 
and sensory block durations were signiﬁ cantly longer in the 
0.75% ropivacaine group in comparison with 2% articaine and 
combination groups. 
Articaine contains thiophene ring instead of benzene ring. 
This structural characteristic increases the lipid solubility of 
articaine and speeds its onset of action 14,15. In addition, we 
know that the pH and pKa of local anesthetics affect their 
onset of action. Previous literature demonstrated that the 
pKa of ropivacaine was 8.05 and that of articaine was 7.8 22. 
As the pKa of articaine is closer to tissue pH, it may have 
contributed to the faster onset we observed. Previous stud-
ies of local anesthetic combinations for regional anesthesia 
combination groups have yielded favorable results in terms of 
onset and duration of anesthesia 10,23-27. Magee et al. 21 admin-
istered epidural anesthesia with bupivacaine alone or with 
bupivacaine-lidocaine mixture and found that combination 
group provides faster sensory block onset than bupivacaine 
alone, although their sensory block durations are similar. 
Cuvillon et al. 24 compared bupivacaine and ropivacaine alone 
with equal volumes of bupivacaine-lidocaine and ropivacaine-
lidocaine mixtures for femoral-sciatic nerve blockade. They 
also concluded that sensory block onset of action was faster 
in combination groups. Ye et al. 25 administered a ropivacaine 
and lidocaine combination for caudal anesthesia and obtained 
faster onset of action and longer anesthesia duration in the 
combination group. Karahan et al. 27 compared epidural 
anesthesia using a combination of 0.5% bupivacaine and 2% 
articaine with 0.5% bupivacaine and found that sensory block 
onset of action and duration was shorter in the combination 
group in comparison with bupivacaine group. Results of these 
studies are parallel to our results, which state that faster 
sensory block onset of action can be obtained by combining 
articaine and ropivacaine.
Morton et al. 28 used 20 mL 0.75% ropivacaine for epi-
dural anesthesia in cesarean operations and found that the 
ﬁ rst dose of local anesthetic provided the targeted T6-S3 
sensory block level by 83%, and the time needed to reach 
maximal sensory block level was 23 minutes. Bjqrnestad 
et al. 29 administered epidural anesthesia with 20 mL 0.75% 
ropivacaine in elective cesarean operations, concluding 
that the maximum sensory block level was T4 and the time 
needed to reach this level was 25 minutes. Both of these 
studies corroborate the results of our study concerning the 
maximal sensory block level and the time needed to reach 
this level in Group R. 
Results of our study in terms of the time needed to reach 
maximum block was shorter in the articaine-ropivacaine 
group in comparison with ropivacaine group. This ﬁ nding is 
parallel with previous studies of epidural anesthesia with 
articaine 27,30.
We did not detect any difference between our groups re-
garding motor block onset times, and found that total motor 
block duration was shorter in the combination group than in 
the ropivacaine group. Parallel to our study, Kaukinen et al. 31 
found a signiﬁ cant decrease in motor block duration in their 
study, where they administered epidural anesthesia with a 
bupivacaine-lidocaine combination. On the other hand, our 
ﬁ ndings contradict those of Donner et al. 32 which state that 
a combination of epidurally administered bupivacaine-prilo-
caine provides faster and more intensive motor block. We are 
also contradicted by Seow et al. 26, in which a combination of 
bupivacaine-lidocaine provides more intensive motor block. 
Table 3  Intraoperative Data of Administered Drugs 
(Mean ± SD).
Group A
(n = 20)
Group AR
(n = 20)
Group R
(n = 20)
First ephedrine 
time (min)
8.4 ± 2.7  a 11.5 ± 5.3 13.3 ± 5.5
Total ephedrine 
(mg)
Fentanyl (μg)
Ketamine (mg)
15.3 ± 10.0  a
32.5 ± 34.0  b
4.5 ± 6.9  b
10.25 ± 9.2 
10.0 ± 20.5 
0.50 ± 2.2 
9.0 ± 7.1 
5.0 ± 11.2 
0.0
a: p < 0.05 (compared to Group R), b: p < 0.05 (compared to 
Groups AR and R).
Table 4  Patient Demand and Bolus Numbers of PCA, Time 
to First Mobilization and Gas Removal According to the 
Groups [Median (min-max), (Mean ± SD)].
      Group A
     (n = 20)
Group AR
(n = 20)
Group R
(n = 20)
Patient demand (n) 16 (9-36) a 14 (5-33) 11 (4-21)
PCA bolus on 
demand (n)
15 (9-29) a 13 (4-20) 9 (4-20)
Time to ﬁ rst 
mobilization (hr)
  9.8 ± 2.4  a 10.7 ± 4.8  a 13.8 ± 2.9
Time to gas 
removal (hr)
20.8 ± 5.1  b 24.8 ± 4.4  a 28.7 ± 5.3
a: p < 0.05 (compared to Group R), b: p < 0.05 (compared to 
Groups AR and R).
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In our study, motor block duration and level in the combina-
tion group was shorter and lower than the ropivacaine group, 
which we believe might have been caused by the fact that 
the differential block effect of ropivacaine emerges with 
greater strength in lower concentrations 11-13,33. 
Furthermore, the number of patients in the articaine 
group with VAS ≥ 3 was higher. In line with this ﬁ nding, the 
amount of intraoperatively consumed fentanyl and ketamine 
was higher in the articaine group than others (Table 3). In a 
study where they used 0.75% ropivacaine epidurally in ce-
sarean operations, Bjqrnestad et al. 29 and Irestedt et al. 34 
identiﬁ ed similar amounts of additional analgesic need, as 
was the case with our study’s ropivacaine group. 
With the neuroaxial blocks for cesarean section, hypoten-
sion is common. This is partially due to sympathetic block 
and tends to be treated with ephedrine, phenylephrine and 
crystalloid-colloid solution infusions 2,3,35-37. In our study, onset 
of hypotension was earlier in the articaine group than in other 
groups; thus, the ﬁ rst ephedrine administration happened 
earlier than with other groups. This was due to more rapid 
sympathetic block effects obtained from the articaine group. 
We believe the higher MBP values from the articaine group 
to be the result of higher ephedrine consumption. The lit-
erature shows that epidural analgesia reduces postoperative 
pain and contributes to early mobilization, allowing earlier 
return of bowel functions, shortening hospitalization, and 
reducing costs 38-40. In ﬁ ndings similar to our study, shorter 
ﬁ rst mobilization and gas removal times in the combination 
group is a result of shorter total motor and sensory block 
durations, which are favorable outcomes for cesarean section 
patients undergoing epidural anesthesia.
Studies of local anesthetic combinations aim to keep the 
beneﬁ ts of the additive effects of the two local anesthet-
ics, and avoid toxicity derived from the use of high volume 
primary medication for epidural and peripheral blocks 21,41,42. 
Peak plasma concentrations of local anesthetics in the 
present study were not determined in this trial; thus, the 
safety of a ropivacaine-articaine combination in terms of 
high plasma local anesthetic concentrations remains to be 
determined. This would be an unexpected clinical scenario, 
however, considering the different pharmacokinetic proﬁ les 
of these two drugs.
In conclusion, a combination of 0.75% ropivacaine with 2% 
articaine provides faster onset of action, earlier mobilization 
and gas removal time in comparison with 0.75% ropivacaine 
alone, as well as resulting in high patient and surgeon satis-
faction rate. A 2% articaine-0.75% ropivacaine combination 
for epidural anesthesia of cesarean section should be pre-
ferred over epidural 0.75% ropivacaine alone.
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